1. Kahn CR. Insulin action,
diabetogeneses, and the cause of type II diabetes. Diabetes. 1994; 43:1066.
2.
American Diabetes Association. Report of the expert committee on the diagnosis
and classification of diabetes mellitus. Diabetes Care 2003; 26: S5-S20.
3.
American Diabetes Association. Follow-up report on the diagnosis of diabetes
mellitus. Diabetes Care.2003; 26 (11): 3160-3167.
4.
Knowler WC, Barret-Connor E, Fowler SE. Reduction in the incidence of type 2
diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346:
393-403.
5.
Benjamin SM, Valdez R, Geiss LS, Rolka DB, Narayan KM. Estimated number of
adults with prediabetes in the US IN 2000: opportunities for prevention.
Diabetes Care. 2003; 26: 645-9.
6.
Rathman W, Giani G. Global prevalence of diabetes: estimates for the year 2000
and projections for 2030. Diabetes Care. 2004; 27: 2568-9.
7.
Kaufman FR. Type 2 diabetes mellitus in children and youth: a new epidemic. J
Pediat Endocrinol Metab. 2002; 15 (2): 737-44.
8.
Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in
children and adolescents. J Pedriatr. 2005; 146:693-700.
9.
Marcovecchio M, Mohn A, Chiarelli F. Type 2 diabetes mellitus in children and
adolescents. J Endocrinol Invest. 2005; 28: 853-63.
10.
Garber AJ, Handelsman Y, Einhorn D. Diagnosis and management of prediabetes in
the continuum of hyperglycemia: When do the risks of diabetes begin? A
consensus statement from the American College of Endocrinologists. Endocr
Pract. 2008; 14: 933-46.
11. Organización Mundial de la Salud.
who.int. Día Mundial de la Diabetes [en
línea]. Venezuela: OMS; 2011
[actualizado marzo 2012; accesado 10 de
febrero de 2012]. Disponible en:
http://www.who.int/mediacentre/events/annual/world_diabetes_day/es/index.html
12. Méndez Castellano H y col. Estudio
Nacional de Crecimiento y Desarrollo Humano de la República de Venezuela. Proyecto Venezuela.
Caracas: Don Bosco; 1996.
13.
ChaoyangL, Earl S, Guixiang Z, Ali H. Prevalence of pre-diabetes and its association withclustering of cardiometabolic
risk factors and hyperinsulinemia among US adolescents. Diabetes Care. 2009;
32: 347.
14.
Invitti C, Guzzaloni G, Gilardini L, Morabito F, Vibertti G. Prevelence and
concomitants of glucose intolerance in European obese children and adolescents.
Diabetes Care. 2003; 26:118.
15. Guijarro M, Monereo S, Civantos S,
Montano J, Bolaños P, Durán M. Prevalencia de alteraciones del metabolismo
hidrocarbonado en una población infanto-juvenil con obesidad grave. Endocrinol Nutrr.
2010; 57:467-71.
16. Licea M, Bustamante M, Lemane M.
Diabetes tipo 2 en niños y adolescentes: aspectos clínico-epidemiológicos,
patogénicos y terapéuticos. Revista Cubana de Endocrinología [en linea] 2008
[acceso 12 de febrero de 2012]; 19 (1): [22p.] Disponible en:
http://scielo.sld.cu/scielo.php?pid=S1561-29532008000100007&script=sci_arttext&tlng=es.
17.
Rodriguez M, Guerrero F, Aradillas C. Obesity and family history of diabetes as
risk factors of impaires fasting glucose: implications for the early detection
of prediabetes. Pediatr Diabetes. 2003; 11:331.
18.
De Graaf C, Bloom W, Smeets P, Stafleu A, Hendriks H. Biomarkers of satiation
and satiety. Am J Clin Nutr. 2004;
79:946-61.
19. Universidad de Navarra [sede Web].
Madrid: Noticias Universidad de Navarra;
2011 [actualizado 26 de mayo de 2011]. Palou
A y cols. ''La leptina, presente en la leche materna, previene la obesidad y la
diabetes''. Disponible en http://www.unav.edu/web/vida-universitaria/detalle-noticia-pestanaíarticleId=296316
20. Wertheimer E, Enk C. Piel y diabetes
mellitus. En: Le Roith D, Taylor S, Olefsky J. Diabetes Mellitus. Fundamentos y
Clínica. 2a ed. México: McGraw Hill; 2003. p. 1198-1207.
21.Diabetes in Michigan [en linea]. Michigan: Michigan"™s Diabetes Outreach Network; 2007 [acceso 15 de febrero de 2012]. ADA Screening Guidelines for Prediabetes
and Diabetes in a Medical Setting 2005; [1 página].
Disponible en:
http://www.diabetesinmichigan.org/EdHandout/PDF/ADAscreenguidelinesmedsetting.pdf
